{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T17:49:20Z","timestamp":1789148960725,"version":"build-2803163510"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T00:00:00Z","timestamp":1664496000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T00:00:00Z","timestamp":1664496000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81973133"],"award-info":[{"award-number":["81973133"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81730019"],"award-info":[{"award-number":["81730019"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Sex Differ"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objectives<\/jats:title>\n                <jats:p>The association between habitual glucosamine use and incident gout has not been examined in previous studies. We aimed to evaluate the association of habitual use of glucosamine with the risk of gout in general population.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A total of 436,594 participants (55.4% female) without prior gout at baseline who completed a questionnaire on supplementation use, which included glucosamine, in the UK Biobank were enrolled. Incident gout was recorded from self-report, death register, primary care, and hospital admission data.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>At baseline, 53,433 (22.1%) females and 30,685 (15.8%) males reported habitual glucosamine use. During a median follow-up period of 12.1\u00a0years, 1718 (0.7%) females and 5685 (2.9%) males developed gout. After multivariable adjustment for major risk factors, glucosamine use was associated with a significantly lower risk of incident gout in females (hazard ratio [HR], 0.81, 95% confidence interval [CI], 0.71\u20130.92), but not in males (HR, 1.05, 95% CI, 0.97\u20131.13), compared with non-use (<jats:italic>P<\/jats:italic>-interaction\u2009&lt;\u20090.001). Among females, the inverse association between glucosamine use and gout was stronger in participants with diuretics use (HR, 0.64, 95% CI, 0.50\u20130.81) than those without diuretics use (HR, 0.89, 95% CI, 0.77\u20131.03) (<jats:italic>P<\/jats:italic>-interaction\u2009=\u20090.015). Moreover, gout genetic risk scores did not significantly modify the association between glucosamine use and the risk of incident gout in males (<jats:italic>P<\/jats:italic>-interaction\u2009=\u20090.548) or females (<jats:italic>P<\/jats:italic>-interaction\u2009=\u20090.183).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Habitual glucosamine use to relieve osteoarthritis pain was related to lower risk of gout in females, but not in males.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13293-022-00461-z","type":"journal-article","created":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T23:04:02Z","timestamp":1664492642000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Associations of habitual glucosamine supplementation with incident gout: a large population based cohort study"],"prefix":"10.1186","volume":"13","author":[{"given":"Mengyi","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziliang","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanjun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sisi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qimeng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panpan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqin","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7812-7982","authenticated-orcid":false,"given":"Xianhui","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,30]]},"reference":[{"issue":"10287","key":"461_CR1","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1016\/S0140-6736(21)00569-9","volume":"397","author":"N Dalbeth","year":"2021","unstructured":"Dalbeth N, Gosling AL, Gaffo A, Abhishek A. Gout. Lancet. 2021;397(10287):1843\u201355.","journal-title":"Lancet"},{"issue":"11","key":"461_CR2","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1002\/art.41404","volume":"72","author":"S Safiri","year":"2020","unstructured":"Safiri S, Kolahi AA, Cross M, Carson-Chahhoud K, Hoy D, Almasi-Hashiani A, Sepidarkish M, Ashrafi-Asgarabad A, Moradi-Lakeh M, Mansournia MA, Kaufman JS, Collins G, Woolf AD, March L, Smith E. Prevalence, incidence, and years lived with disability due to gout and its attributable risk factors for 195 countries and territories 1990\u20132017: a systematic analysis of the global burden of disease study 2017. Arthritis Rheumatol. 2020;72(11):1916\u201327.","journal-title":"Arthritis Rheumatol"},{"issue":"21","key":"461_CR3","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1001\/jama.2016.3517","volume":"315","author":"SY Lim","year":"2016","unstructured":"Lim SY, Lu N, Oza A, Fisher M, Rai SK, Menendez ME, Choi HK. Trends in gout and rheumatoid arthritis hospitalizations in the United States, 1993\u20132011. JAMA. 2016;315(21):2345\u20137.","journal-title":"JAMA"},{"issue":"2","key":"461_CR4","doi-asserted-by":"publisher","first-page":"164","DOI":"10.18553\/jmcp.2008.14.2.164","volume":"14","author":"EQ Wu","year":"2008","unstructured":"Wu EQ, Patel PA, Yu AP, Mody RR, Cahill KE, Tang J, Krishnan E. Disease-related and all-cause health care costs of elderly patients with gout. J Manag Care Pharm. 2008;14(2):164\u201375.","journal-title":"J Manag Care Pharm"},{"issue":"7","key":"461_CR5","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/s41584-020-0441-1","volume":"16","author":"M Dehlin","year":"2020","unstructured":"Dehlin M, Jacobsson L, Roddy E. Global epidemiology of gout: prevalence, incidence, treatment patterns and risk factors. Nat Rev Rheumatol. 2020;16(7):380\u201390.","journal-title":"Nat Rev Rheumatol"},{"key":"461_CR6","doi-asserted-by":"crossref","unstructured":"Jordan KM, Arden NK, Doherty M, Bannwarth B, Bijlsma JW, Dieppe P, Gunther K, Hauselmann H, Herrero-Beaumont G, Kaklamanis P, Lohmander S, Leeb B, Lequesne M, Mazieres B, Martin-Mola E, Pavelka K, Pendleton A, Punzi L, Serni U, Swoboda B, Verbruggen G, Zimmerman-Gorska I, Dougados M; Standing Committee for International Clinical Studies Including Therapeutic Trials ESCISIT. EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis. 2003;62(12):1145\u201355.","DOI":"10.1136\/ard.2003.011742"},{"key":"461_CR7","first-page":"471","volume":"78","author":"S Dahmer","year":"2008","unstructured":"Dahmer S, Schiller RM. Glucosamine. Am Fam Physician. 2008;78:471\u20136.","journal-title":"Am Fam Physician"},{"issue":"11","key":"461_CR8","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/nrrheum.2017.155","volume":"13","author":"AK So","year":"2017","unstructured":"So AK, Martinon F. Inflammation in gout: mechanisms and therapeutic targets. Nat Rev Rheumatol. 2017;13(11):639\u201347.","journal-title":"Nat Rev Rheumatol"},{"key":"461_CR9","doi-asserted-by":"publisher","first-page":"737","DOI":"10.7326\/L19-0123","volume":"170","author":"N Schlesinger","year":"2019","unstructured":"Schlesinger N. Relationship of interleukin-1beta blockade with incident gout and serum uric acid levels. Ann Intern Med. 2019;170:737\u20138.","journal-title":"Ann Intern Med"},{"issue":"3","key":"461_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001779","volume":"12","author":"C Sudlow","year":"2015","unstructured":"Sudlow C, Gallacher J, Allen N, Beral V, Burton P, Danesh J, Downey P, Elliott P, Green J, Landray M, Liu B, Matthews P, Ong G, Pell J, Silman A, Young A, Sprosen T, Peakman T, Collins R. UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 2015;12(3): e1001779.","journal-title":"PLoS Med"},{"key":"461_CR11","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1016\/S0140-6736(12)60404-8","volume":"379","author":"R Collins","year":"2012","unstructured":"Collins R. What makes UK Biobank special? Lancet. 2012;379:1173\u20134.","journal-title":"Lancet"},{"issue":"9","key":"461_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0162388","volume":"11","author":"SV Eastwood","year":"2016","unstructured":"Eastwood SV, Mathur R, Atkinson M, Brophy S, Sudlow C, Flaig R, de Lusignan S, Allen N, Chaturvedi N. Algorithms for the capture and adjudication of prevalent and incident diabetes in UK Biobank. PLoS ONE. 2016;11(9): e0162388.","journal-title":"PLoS ONE"},{"key":"461_CR13","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n604","volume":"373","author":"YB Zhang","year":"2021","unstructured":"Zhang YB, Chen C, Pan XF, Guo J, Li Y, Franco OH, Liu G, Pan A. Associations of healthy lifestyle and socioeconomic status with mortality and incident cardiovascular disease: two prospective cohort studies. BMJ. 2021;373: n604.","journal-title":"BMJ"},{"key":"461_CR14","doi-asserted-by":"crossref","unstructured":"Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604\u201312.","DOI":"10.7326\/0003-4819-150-9-200905050-00006"},{"issue":"7726","key":"461_CR15","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41586-018-0579-z","volume":"562","author":"C Bycroft","year":"2018","unstructured":"Bycroft C, Freeman C, Petkova D, Band G, Elliott LT, Sharp K, Motyer A, Vukcevic D, Delaneau O, O\u2019Connell J, Cortes A, Welsh S, Young A, Effingham M, McVean G, Leslie S, Allen N, Donnelly P, Marchini J. The UK Biobank resource with deep phenotyping and genomic data. Nature. 2018;562(7726):203\u20139.","journal-title":"Nature"},{"issue":"9","key":"461_CR16","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1136\/annrheumdis-2020-219796","volume":"80","author":"G Sandoval-Plata","year":"2021","unstructured":"Sandoval-Plata G, Morgan K, Abhishek A. Variants in urate transporters, ADH1B, GCKR and MEPE genes associate with transition from asymptomatic hyperuricaemia to gout: results of the first gout versus asymptomatic hyperuricaemia GWAS in Caucasians using data from the UK Biobank. Ann Rheum Dis. 2021;80(9):1220\u20136.","journal-title":"Ann Rheum Dis"},{"issue":"24","key":"461_CR17","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1056\/NEJMoa1605086","volume":"375","author":"AV Khera","year":"2016","unstructured":"Khera AV, Emdin CA, Drake I, Natarajan P, Bick AG, Cook NR, Chasman DI, Baber U, Mehran R, Rader DJ, Fuster V, Boerwinkle E, Melander O, Orho-Melander M, Ridker PM, Kathiresan S. Genetic risk, adherence to a healthy lifestyle, and coronary disease. N Engl J Med. 2016;375(24):2349\u201358.","journal-title":"N Engl J Med"},{"issue":"4","key":"461_CR18","doi-asserted-by":"publisher","first-page":"719","DOI":"10.2337\/dc19-1836","volume":"43","author":"H Ma","year":"2020","unstructured":"Ma H, Li X, Zhou T, Sun D, Liang Z, Li Y, Heianza Y, Qi L. Glucosamine use, inflammation, and genetic susceptibility, and incidence of type 2 diabetes: a prospective study in UK Biobank. Diabetes Care. 2020;43(4):719\u201325.","journal-title":"Diabetes Care"},{"key":"461_CR19","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l1628","volume":"365","author":"H Ma","year":"2019","unstructured":"Ma H, Li X, Sun D, Zhou T, Ley SH, Gustat J, Heianza Y, Qi L. Association of habitual glucosamine use with risk of cardiovascular disease: prospective study in UK Biobank. BMJ. 2019;365: l1628.","journal-title":"BMJ"},{"issue":"6","key":"461_CR20","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1136\/annrheumdis-2020-217176","volume":"79","author":"ZH Li","year":"2020","unstructured":"Li ZH, Gao X, Chung VC, Zhong WF, Fu Q, Lv YB, Wang ZH, Shen D, Zhang XR, Zhang PD, Li FR, Huang QM, Chen Q, Song WQ, Wu XB, Shi XM, Kraus VB, Yang X, Mao C. Associations of regular glucosamine use with all-cause and cause-specific mortality: a large prospective cohort study. Ann Rheum Dis. 2020;79(6):829\u201336.","journal-title":"Ann Rheum Dis"},{"key":"461_CR21","doi-asserted-by":"crossref","unstructured":"Zhang XR, Zhang PD, Li ZH, Yang P, Wang XM, Liu HM, Liang F, Wang JD, Sun Y, Shen D, Chen PL, Zhong WF, Huang QM, Liu D, Wang ZH, Kraus VB, Mao C. Glucosamine use, smoking and risk of incident chronic obstructive pulmonary disease: a large prospective cohort study. Br J Nutr. 2021:1\u201312.","DOI":"10.1017\/S000711452100372X"},{"issue":"4","key":"461_CR22","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/S1063-4584(03)00028-1","volume":"11","author":"R Largo","year":"2003","unstructured":"Largo R, Alvarez-Soria MA, D\u00edez-Ortego I, Calvo E, S\u00e1nchez-Pernaute O, Egido J, Herrero-Beaumont G. Glucosamine inhibits IL-1beta-induced NFkappaB activation in human osteoarthritic chondrocytes. Osteoarthr Cartil. 2003;11(4):290\u20138.","journal-title":"Osteoarthr Cartil"},{"key":"461_CR23","first-page":"205","volume":"22","author":"S Yomogida","year":"2008","unstructured":"Yomogida S, Hua J, Sakamoto K, Nagaoka I. Glucosamine suppresses interleukin-8 production and ICAM-1 expression by TNF-alpha-stimulated human colonic epithelial HT-29 cells. Int J Mol Med. 2008;22:205\u201311.","journal-title":"Int J Mol Med"},{"key":"461_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2020.101482","volume":"31","author":"DN Di Florio","year":"2020","unstructured":"Di Florio DN, Sin J, Coronado MJ, Atwal PS, Fairweather D. Sex differences in inflammation, redox biology, mitochondria and autoimmunity. Redox Biol. 2020;31: 101482.","journal-title":"Redox Biol"},{"key":"461_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bcp.2017.06.128","volume":"145","author":"S Pace","year":"2017","unstructured":"Pace S, Sautebin L, Werz O. Sex-biased eicosanoid biology: impact for sex differences in inflammation and consequences for pharmacotherapy. Biochem Pharmacol. 2017;145:1\u201311.","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"461_CR26","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.bbrc.2011.01.007","volume":"405","author":"K Imagawa","year":"2011","unstructured":"Imagawa K, de Andr\u00e9s MC, Hashimoto K, Pitt D, Itoi E, Goldring MB, Roach HI, Oreffo RO. The epigenetic effect of glucosamine and a nuclear factor-kappa B (NF-kB) inhibitor on primary human chondrocytes\u2014implications for osteoarthritis. Biochem Biophys Res Commun. 2011;405(3):362\u20137.","journal-title":"Biochem Biophys Res Commun"},{"key":"461_CR27","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3390\/nu13010047","volume":"13","author":"MF McCarty","year":"2021","unstructured":"McCarty MF, Iloki Assanga SB, Lewis Luj\u00e1n L, O Keefe JH, DiNicolantonio JJ. Nutraceutical strategies for suppressing NLRP3 inflammasome activation: pertinence to the management of COVID-19 and beyond. Nutrients. 2021;13:47.","journal-title":"Nutrients"},{"issue":"7140","key":"461_CR28","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/nature05746","volume":"447","author":"TA Reese","year":"2007","unstructured":"Reese TA, Liang HE, Tager AM, Luster AD, Van Rooijen N, Voehringer D, Locksley RM. Chitin induces accumulation in tissue of innate immune cells associated with allergy. Nature. 2007;447(7140):92\u20136.","journal-title":"Nature"},{"issue":"1","key":"461_CR29","doi-asserted-by":"publisher","first-page":"5603","DOI":"10.1038\/s41598-019-42130-z","volume":"9","author":"HW Chiu","year":"2019","unstructured":"Chiu HW, Li LH, Hsieh CY, Rao YK, Chen FH, Chen A, Ka SM, Hua KF. Glucosamine inhibits IL-1\u03b2 expression by preserving mitochondrial integrity and disrupting assembly of the NLRP3 inflammasome. Sci Rep. 2019;9(1):5603.","journal-title":"Sci Rep"}],"container-title":["Biology of Sex Differences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13293-022-00461-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13293-022-00461-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13293-022-00461-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T23:21:42Z","timestamp":1664493702000},"score":1,"resource":{"primary":{"URL":"https:\/\/bsd.biomedcentral.com\/articles\/10.1186\/s13293-022-00461-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,30]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["461"],"URL":"https:\/\/doi.org\/10.1186\/s13293-022-00461-z","relation":{},"ISSN":["2042-6410"],"issn-type":[{"value":"2042-6410","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,30]]},"assertion":[{"value":"17 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The UK Biobank was approved by the North West Research Ethics Committee (06\/MRE08\/65) and all participants signed an informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"No disclosure was reported.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"52"}}